1. VENUS REMEDIES
stock logo

100% Buy

VENUS REMEDIES Share Price

VENUSREM

₹315.35-₹8.80 (-2.71%) TodayLast updated on 08 Nov, 2024 | 15:29 IST

VENUS REMEDIES Share Price Chart

Please wait...
  • About VENUS REMEDIES
  • Fundamentals
  • More
  • News

About VENUS REMEDIES

VENUS REMEDIES Financials

arrow
Market cap
Market Cap Switch₹424 Crs
Open
₹324.15
Close
₹324.15
Circuit range
₹380.70 - ₹253.80
Day range
₹315.20 - ₹329.00
Year range
₹281.10 - ₹430.00
Volume
44,993
Avg. traded
₹321.67
Revenue (12m)
₹615 Crs
VENUS REMEDIESVenus Remedies Ltd is a research-driven pharmaceutical company. The Company is a global injectable manufacturer. It manufactures products catering to critical care segments such as antimicrobial resistance, anti-cancer, Anti-infective, Neurology, Skin and Wound Care, and Pain Management. With a diverse portfolio of innovative and high-quality products, the Company is dedicated to revolutionizing patient care through its specialized therapeutic segments such as anti-infective (antibiotics), oncology, neurology, pain management, and skin & wound care. The Company operates only in one business segment: Pharmaceutical Formulation and is engaged in manufacturing and trading of medicines. Its focus therapy areas include medicine, surgery, neuro and orthopedics. The Company’s brands include Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, and others. It has three manufacturing facilities: Panchkula and Baddi in India and Werne in Germany.

Venus Remedies Key indicators

arrow
52 week high
₹430.00
52 week low
₹281.10
P/E ratio
19.16
P/B ratio
0.84
ROE
6.18%
ROCE
8.77%
Dividend yield
--
Debt/Equity ratio
0.08
EPS
22.82

Learn more

Investment checklist: (3/6)
arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 1 experts in the last 7 days

VENUS REMEDIES Fundamentals

VENUS REMEDIES Financial Ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

12.55%

Net profit margin

5.3%

ROE

6.18%

ROA

4.88%

ROCE

8.77%

Learn more

VENUS REMEDIES Shareholder returns

arrow
1 day
-2.13%
1 week
+1.23%
1 month
-3.32%
3 months
-20.79%
1 year
+10.18%
3 years
-37.82%
5 years
+1194.90%

Venus Remedies Share Price history

arrow
DayOpenCloseChange %
Fri, Nov 8 2024
₹324.15
₹317.25
-2.13%
Thu, Nov 7 2024
₹325.40
₹324.15
+0.89%
Wed, Nov 6 2024
₹313.65
₹321.30
+3.65%
Tue, Nov 5 2024
₹314.50
₹310.00
+0.03%
Mon, Nov 4 2024
₹315.95
₹309.90
-1.12%
Fri, Nov 1 2024
₹318.40
₹313.40
+0.63%
Thu, Oct 31 2024
₹309.70
₹311.45
+0.57%
Wed, Oct 30 2024
₹330.00
₹309.70
-9.87%

VENUS REMEDIES Shareholding Pattern

arrow

Promoters (41.76%)

Mutual Funds (0%)

Retail and other (57.06%)

Foreign institutions-FII (1.18%)

Other domestic institutions (0%)

Retail and other

Learn more

FAQs on VENUS REMEDIES

What is the Venus Remedies share price today?

chevron-up
Venus Remedies share price is ₹ 315.35 today.

What is today’s high & low share price of Venus Remedies?

chevron-up
Venus Remedies share price high: ₹ 329.00 and low: ₹ 315.20

What is the Venus Remedies share price high and low in the last 52 weeks on the NSE?

chevron-up
52 Week share High Price is ₹ 430.00 and Low Price is ₹ 281.10

What is the Venus Remedies Stock Symbol?

chevron-up
The Venus Remedies Stock symbol is VENUSREM.

Can I buy Venus Remedies shares on Holidays?

chevron-up
No, shares of Venus Remedies or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Venus Remedies shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.